Evidence map›Paper›PMID 35456553›Full record

ArticlePharmaceutics2022

Diphlorethohydroxycarmalol Derived from

Bomi Ryu, Seyeon Oh, Hye-Won Yang, Batsukh Sosorburam, Dong-Min Chung, Minyoung Seo, Shin-Jae Park, Kyunghee Byun, You-Jin Jeon

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Effect ofFrontiers in nutrition · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Bomi RyuDepartment of Marine Life Science, School of Marine Biomedical Sciences, Jeju National University, Jeju 63243, Korea.ORCID 0000-0001-5797-500X
Seyeon OhFunctional Cellular Networks Laboratory, Department of Medicine, Graduate School, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21999, Korea.
Hye-Won YangDepartment of Marine Life Science, School of Marine Biomedical Sciences, Jeju National University, Jeju 63243, Korea.
Batsukh SosorburamFunctional Cellular Networks Laboratory, Department of Medicine, Graduate School, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21999, Korea.
Dong-Min ChungShinwoo Co., Ltd., Jinju 52839, Korea.
Minyoung SeoShinwoo Co., Ltd., Jinju 52839, Korea.
Shin-Jae ParkShinwoo Co., Ltd., Jinju 52839, Korea.
Kyunghee ByunFunctional Cellular Networks Laboratory, Department of Medicine, Graduate School, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21999, Korea.
You-Jin JeonDepartment of Marine Life Science, School of Marine Biomedical Sciences, Jeju National University, Jeju 63243, Korea.ORCID 0000-0003-3299-7266
Gachon University · KRJeju National University · KR

Funding

Ministry of Oceans and Fisheries 20170285
6 · The paper itself

Abstract

Muscle atrophy refers to the loss of skeletal muscle mass, myofiber size, and related physical functions such as walking speed or grip strength caused by aging or a lack of physical activity due to injury or illness and can also be attributed to excessive exposure to corticosteroids.

Indexed as

dexamethasone (DEX)diphlorethohydroxycarmalol (DPHC)Ishige okamurae (IO)metabolic propertymuscle atrophyphysical function

Identifiers

PMID35456553
PMCPMC9026865
OpenAlexW4220985136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.